Evofem biosciences inc

Major-Pharmaceuticals

EVFM


12400 High Bluff Drive
San Diego , CA 92130

Executive/
Director

Price

  • Last Close
  • $ 0.08
    $ +0 1.27 %
    Dec 9, 2022
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 1,651,100
  • Market Cap Full
  • $ 858.4K
  • Shares Outstanding
  • 10.7M
    Nov 9, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - -16.5% -5% -28.1% -11.5% - -
Q2 - - - -56.6% 85.9% 4% -35.6% 232.4% - -
Q3 - - - 64.6% -11.9% 8% -34.9% -85% - -
Q4 - - - 0.5% 27.1% - -47.8% -52.9% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 - - - - - - - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%55%-62%-84%-79%0%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.50 0.44 0.22 -4.62 -0.67 - - - -1.85
Q2 0.69 0.19 0.20 -1.11 -0.97 - - - -5.43
Q3 1.26 0.17 0.13 -0.71 -0.3 - (19.09) (1.65) 0.10
Q4 0.69 0.14 - 0.7 -1.99 -2.12 -23.69 768.75 -
A 3.1 0.9 0.6 -5.7 -3.9 -2.1 -23.6 -1.3 -7.18

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 28.2 49.6 83.1 167.8 -
Jun 17.8 35.4 49.7 102.8 12.7 2.3
Sep 25.8 46.6 81.3 155.2 85.5 4.1
Dec 25.9 46.8 81.3 163.1 121.2 10.7

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 0.8 0.5 - - -
Fixed Asset Turnover 2.1 1.1 - - -
Total Asset Turnover 0.7 0.2 - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 12 -4.4 -2.7 -2 -1.6
Equity multiplier -0.1 -0.1 5 0.1 -0.1